The American biotechnology landscape is currently undergoing a period of unprecedented transformation, driven by rapid advancements in genetic engineering, artificial intelligence, and precision medicine. As the global healthcare sector pivots toward more personalized and targeted therapeutic interventions, the companies leading these efforts are fundamentally altering the prognosis for complex diseases. This article explores the organizations […]